Showing results (31-40 of 768) with videos related to
Sort By:
Pageof 77
Clinical Immunology (Orlando, Fla.)|April 20, 2004
Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasisAlice B Gottlieb, Sewon Kang, Kenneth G Linden, et al.Clinics in Dermatology|June 23, 2009
The ethics of consulting with pharmaceutical companiesAndrew Miner, Alan MenterJournal of Drugs in Dermatology : JDD|March 17, 2017
Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With UstekinumabLauren Dickson, Alan MenterAmerican Journal of Clinical Dermatology|April 30, 2002
Novel therapies for psoriasisJennifer Cather, Alan MenterDermatologic Clinics|September 29, 2004
Psoriasis and its treatment with infliximab-mediated tumor necrosis factor alpha blockadeLaura Winterfield, Alan MenterExpert Opinion on Investigational Drugs|October 1, 2016
A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studiesMolly Campa, Alan MenterProceedings (Baylor University. Medical Center)|January 2, 2015
The Laugier-Hunziker syndromeTahmina Mahmood, Alan MenterExpert Review of Clinical Immunology|January 14, 2014
Ustekinumab for the treatment of psoriatic arthritisJay Wofford, Alan MenterJournal of the American Academy of Dermatology|August 2, 2003
Combining the new biologic agents with our current psoriasis armamentariumMark LebwohlThe Journal of Investigative Dermatology|July 25, 2017
Does Treatment of Psoriasis Reduce Cardiovascular Comorbidities?Mark LebwohlPageof 77